Ildong Holdings Co Ltd (000230) - Net Assets
Based on the latest financial reports, Ildong Holdings Co Ltd (000230) has net assets worth ₩345.58 Billion KRW (≈ $234.19 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩802.86 Billion ≈ $544.09 Million USD) and total liabilities (₩457.28 Billion ≈ $309.89 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 000230 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩345.58 Billion |
| % of Total Assets | 43.04% |
| Annual Growth Rate | 7.26% |
| 5-Year Change | 88.49% |
| 10-Year Change | 223.46% |
| Growth Volatility | 29.88 |
Ildong Holdings Co Ltd - Net Assets Trend (1999–2025)
This chart illustrates how Ildong Holdings Co Ltd's net assets have evolved over time, based on quarterly financial data. See Ildong Holdings Co Ltd (000230) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Ildong Holdings Co Ltd (1999–2025)
The table below shows the annual net assets of Ildong Holdings Co Ltd from 1999 to 2025. For live valuation and market cap data, see market cap of Ildong Holdings Co Ltd.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩345.58 Billion ≈ $234.19 Million |
+36.06% |
| 2024-12-31 | ₩254.00 Billion ≈ $172.13 Million |
+49.50% |
| 2023-12-31 | ₩169.90 Billion ≈ $115.14 Million |
+0.47% |
| 2022-12-31 | ₩169.10 Billion ≈ $114.60 Million |
-7.77% |
| 2021-12-31 | ₩183.34 Billion ≈ $124.25 Million |
-40.01% |
| 2020-12-31 | ₩305.61 Billion ≈ $207.11 Million |
-4.82% |
| 2019-12-31 | ₩321.09 Billion ≈ $217.60 Million |
+94.67% |
| 2018-12-31 | ₩164.95 Billion ≈ $111.78 Million |
-5.55% |
| 2017-12-31 | ₩174.64 Billion ≈ $118.35 Million |
+63.46% |
| 2016-12-31 | ₩106.84 Billion ≈ $72.40 Million |
-69.47% |
| 2015-12-31 | ₩349.98 Billion ≈ $237.18 Million |
+5.12% |
| 2014-12-31 | ₩332.95 Billion ≈ $225.64 Million |
+1.94% |
| 2013-12-31 | ₩326.60 Billion ≈ $221.34 Million |
+0.67% |
| 2012-12-31 | ₩324.42 Billion ≈ $219.85 Million |
+4.59% |
| 2011-12-31 | ₩310.17 Billion ≈ $210.20 Million |
+5.14% |
| 2010-12-31 | ₩295.00 Billion ≈ $199.92 Million |
+5.26% |
| 2009-12-31 | ₩280.27 Billion ≈ $189.94 Million |
+35.49% |
| 2008-12-31 | ₩206.86 Billion ≈ $140.19 Million |
+5.67% |
| 2007-12-31 | ₩195.76 Billion ≈ $132.66 Million |
+13.16% |
| 2006-12-31 | ₩172.99 Billion ≈ $117.23 Million |
+17.86% |
| 2005-12-31 | ₩146.78 Billion ≈ $99.47 Million |
+17.46% |
| 2004-12-31 | ₩124.97 Billion ≈ $84.69 Million |
+18.22% |
| 2003-12-31 | ₩105.71 Billion ≈ $71.64 Million |
+11.46% |
| 2002-12-31 | ₩94.84 Billion ≈ $64.27 Million |
+19.49% |
| 2001-12-31 | ₩79.37 Billion ≈ $53.79 Million |
+18.50% |
| 2000-12-31 | ₩66.98 Billion ≈ $45.39 Million |
+20.01% |
| 1999-12-31 | ₩55.81 Billion ≈ $37.82 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Ildong Holdings Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 12068228473000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ₩289.44 Billion | 171.51% |
| Total Equity | ₩168.76 Billion | 100.00% |
Ildong Holdings Co Ltd Competitors by Market Cap
The table below lists competitors of Ildong Holdings Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Grupo Ezentis S.A
MC:EZE
|
$53.57 Million |
|
Cross Timbers Royalty Trust
NYSE:CRT
|
$53.58 Million |
|
Tex-Ray Industrial Co Ltd
TW:1467
|
$53.58 Million |
|
ABO Group
BR:ABO
|
$53.62 Million |
|
BitFuFu Inc. Class A Ordinary Shares
NASDAQ:FUFU
|
$53.52 Million |
|
Epitomee Medical Ltd
TA:EPIT
|
$53.52 Million |
|
Formet Celik Kapi Sanayi ve Ticaret AS
IS:FORMT
|
$53.51 Million |
|
Iris Business Services Limited
NSE:IRIS
|
$53.51 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ildong Holdings Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 133,886,190,470 to 168,760,298,200, a change of 34,874,107,730 (26.0%).
- Net income of 10,925,563,420 contributed positively to equity growth.
- Dividend payments of 60,160,000 reduced retained earnings.
- Share repurchases of 865,800 reduced equity.
- Other factors increased equity by 24,009,570,110.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩10.93 Billion | +6.47% |
| Dividends Paid | ₩60.16 Million | -0.04% |
| Share Repurchases | ₩865.80K | -0.0% |
| Other Changes | ₩24.01 Billion | +14.23% |
| Total Change | ₩- | 26.05% |
Book Value vs Market Value Analysis
This analysis compares Ildong Holdings Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.47x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩15335.50 | ₩7000.00 | x |
| 2018-12-31 | ₩15220.59 | ₩7000.00 | x |
| 2019-12-31 | ₩12183.33 | ₩7000.00 | x |
| 2020-12-31 | ₩10866.82 | ₩7000.00 | x |
| 2021-12-31 | ₩4722.60 | ₩7000.00 | x |
| 2022-12-31 | ₩1046.13 | ₩7000.00 | x |
| 2023-12-31 | ₩3450.39 | ₩7000.00 | x |
| 2024-12-31 | ₩11856.64 | ₩7000.00 | x |
| 2025-12-31 | ₩14945.00 | ₩7000.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ildong Holdings Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.47%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.85%
- • Asset Turnover: 0.74x
- • Equity Multiplier: 4.76x
- Recent ROE (6.47%) is above the historical average (-26.29%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1999 | 8.25% | 3.91% | 0.62x | 3.39x | ₩-976.37 Million |
| 2000 | 11.58% | 4.88% | 0.79x | 2.98x | ₩993.77 Million |
| 2001 | 13.48% | 5.33% | 1.01x | 2.50x | ₩2.55 Billion |
| 2002 | 15.51% | 6.49% | 1.08x | 2.21x | ₩4.89 Billion |
| 2003 | 14.23% | 5.89% | 1.09x | 2.21x | ₩4.18 Billion |
| 2004 | 8.43% | 3.51% | 1.21x | 1.99x | ₩-1.84 Billion |
| 2005 | 15.04% | 6.56% | 1.20x | 1.91x | ₩6.81 Billion |
| 2006 | 14.88% | 6.71% | 1.21x | 1.83x | ₩7.58 Billion |
| 2007 | 12.87% | 6.26% | 1.08x | 1.91x | ₩5.04 Billion |
| 2008 | 9.56% | 4.81% | 0.93x | 2.13x | ₩-839.03 Million |
| 2009 | 12.60% | 8.30% | 0.80x | 1.90x | ₩6.77 Billion |
| 2010 | 6.76% | 5.35% | 0.65x | 1.93x | ₩-8.89 Billion |
| 2011 | 8.81% | 7.83% | 0.68x | 1.65x | ₩-3.68 Billion |
| 2012 | 5.22% | 4.66% | 0.67x | 1.67x | ₩-15.49 Billion |
| 2013 | 1.99% | 1.64% | 0.63x | 1.93x | ₩-26.09 Billion |
| 2014 | 3.58% | 2.84% | 0.67x | 1.87x | ₩-21.30 Billion |
| 2015 | 6.03% | 54.78% | 0.05x | 2.03x | ₩-13.83 Billion |
| 2016 | 253.86% | 652.39% | 0.20x | 1.95x | ₩255.51 Billion |
| 2017 | 0.38% | 1.59% | 0.15x | 1.59x | ₩-16.67 Billion |
| 2018 | -2.27% | -7.91% | 0.18x | 1.62x | ₩-20.09 Billion |
| 2019 | -16.32% | -7.69% | 0.36x | 5.85x | ₩-36.22 Billion |
| 2020 | -15.63% | -3.22% | 0.75x | 6.51x | ₩-31.46 Billion |
| 2021 | -132.93% | -11.97% | 0.64x | 17.27x | ₩-76.22 Billion |
| 2022 | -866.44% | -15.15% | 0.78x | 73.02x | ₩-103.53 Billion |
| 2023 | -152.94% | -9.33% | 0.73x | 22.51x | ₩-63.48 Billion |
| 2024 | 47.08% | 9.93% | 0.74x | 6.38x | ₩49.65 Billion |
| 2025 | 6.47% | 1.85% | 0.74x | 4.76x | ₩-5.95 Billion |
Industry Comparison
This section compares Ildong Holdings Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $359,756,676,170
- Average return on equity (ROE) among peers: 3.52%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ildong Holdings Co Ltd (000230) | ₩345.58 Billion | 8.25% | 1.32x | $53.57 Million |
| Dongwha Pharm.Co.Ltd (000020) | $297.40 Billion | 3.39% | 0.25x | $97.49 Million |
| Yuhan Corp. (000100) | $519.03 Billion | 9.81% | 0.47x | $3.90 Billion |
| Yuhan Corp Preferred (000105) | $1.65 Trillion | 3.48% | 0.32x | $51.83 Million |
| Yuyu Pharma (000220) | $128.69 Billion | -1.72% | 0.50x | $43.48 Million |
| Yuyu Pharma Inc (000225) | $120.36 Billion | -5.97% | 0.65x | $14.47 Million |
| Yuyu Pharma Inc (000227) | $86.87 Billion | 4.63% | 0.56x | $42.09 Million |
| Samil Pharm (000520) | $54.41 Billion | 1.08% | 0.83x | $101.43 Million |
| Donga Socio Holdings (000640) | $266.72 Billion | 7.48% | 1.59x | $367.37 Million |
| Jw Pharmac (001060) | $112.60 Billion | 9.51% | 2.66x | $416.42 Million |
About Ildong Holdings Co Ltd
Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the… Read more